| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,341 | 16,340 | 16,340 | 12,578 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 16,341 | 16,340 | 16,340 | 12,578 | | | Operating Expenses | | Research Development | 21,530 | 17,545 | 15,776 | 13,167 | | Selling General and Administrative | 6,034 | 6,611 | 6,305 | 8,333 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (11,223) | (7,816) | (5,741) | (8,922) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 96 | 157 | 560 | 991 | | Earnings Before Interest And Taxes | (11,127) | (7,659) | (5,181) | (7,931) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (11,127) | (7,659) | (5,181) | (7,931) | | Income Tax Expense | 2,846 | 1,264 | 428 |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,973) | (8,923) | (5,609) | (7,931) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (13,973) | (8,923) | (5,609) | (7,931) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,973) | ($8,923) | ($5,609) | ($7,931) |
|
0.83% Nasdaq 0.00%
Income Statement
